Saturday, December 5th 2026

820	Welcome Back Lorraine Kalia
Junior Oral Presentations Chair: Tejas Sankar
830	Oral Presentations
910	Q&A
Ali Rajput Lectureship Chair: Alex Rajput
930	Ali Rajput Lectureship Anthony Lang
1015	BREAK
Developing Canadian clinical guidelines for movement disorders Chair: Silke Cresswell
1030	Canadian guidelines for Parkinson’s disease David Grimes
1050	Canadian guidelines for Dystonia Davide Martino
1110	Canadian guidelines for Ataxia Antoine Duquette
1130	Panel Discussion and Q&A
1150	LUNCH & Poster Session
Novel approaches to abnormal tone and posture
1230	Is there a role for botulinum toxin in management of paratonia? Galit Kleiner
1300	Cryoneurolysis for pathologic muscle overactivity and presumed contracture Paul Winston
1330	Q&A
Establishing a Canadian clinical trials network Chair: Tiago Mestre
1345	Current clinical trial landscape for movement disorders in Canada Nicolas Jodoin
1405	Canadian clinical trial networks: lessons from TBC
1425	Canadian clinical trial networks: lessons from stroke Michael Hill
1445	Panel Discussion and Q&A
1510	Evaluations & Closing Remarks Lorraine Kalia
1530	Adjourn

2026 Canadian Movement Disorders Society Congress